190 related articles for article (PubMed ID: 24377153)
1. Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease.
Guleria A; Duseja A; Kalra N; Das A; Dhiman R; Chawla Y; Bhansali A
Trop Gastroenterol; 2013; 34(2):74-82. PubMed ID: 24377153
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients.
Narayan J; Das HS; Nath P; Singh A; Mishra D; Padhi PK; Singh SP
Int J Hepatol; 2020; 2020():1825142. PubMed ID: 32724678
[TBL] [Abstract][Full Text] [Related]
3. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
[TBL] [Abstract][Full Text] [Related]
4. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
[TBL] [Abstract][Full Text] [Related]
6. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
[TBL] [Abstract][Full Text] [Related]
7. Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study.
Lankarani KB; Mahmoodi M; Lotfi M; Zamiri N; Heydari ST; Ghaffarpasand F; Fallahzadeh MK; Babaeinejad M; Maharlouei N; Mirzaee O; Geramizadeh B; Peymani P
Korean J Gastroenterol; 2013 Dec; 62(6):344-51. PubMed ID: 24365733
[TBL] [Abstract][Full Text] [Related]
8. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
Oni ET; Agatston AS; Blaha MJ; Fialkow J; Cury R; Sposito A; Erbel R; Blankstein R; Feldman T; Al-Mallah MH; Santos RD; Budoff MJ; Nasir K
Atherosclerosis; 2013 Oct; 230(2):258-67. PubMed ID: 24075754
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease.
Kucukazman M; Ata N; Yavuz B; Dal K; Sen O; Deveci OS; Agladioglu K; Yeniova AO; Nazligul Y; Ertugrul DT
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):147-51. PubMed ID: 23085576
[TBL] [Abstract][Full Text] [Related]
10. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
[TBL] [Abstract][Full Text] [Related]
11. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
Bajaj S; Prajapati SK
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845
[TBL] [Abstract][Full Text] [Related]
13. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.
Ampuero J; Gallego-Durán R; Romero-Gómez M
Rev Esp Enferm Dig; 2015 Jan; 107(1):10-6. PubMed ID: 25603326
[TBL] [Abstract][Full Text] [Related]
14. Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population.
Taharboucht S; Guermaz R; Brouri M; Chibane A
J Med Vasc; 2021 May; 46(3):129-138. PubMed ID: 33990287
[TBL] [Abstract][Full Text] [Related]
15. A Study of Correlation between Non Alcoholic Fatty Liver Disease and Carotid Atherosclerosis.
Sagar A; L R; Farheen SA
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443470
[TBL] [Abstract][Full Text] [Related]
16. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease.
Wang B; Zhao Z; Liu S; Wang S; Chen Y; Xu Y; Xu M; Wang W; Ning G; Li M; Wang T; Bi Y
Diabetes Res Clin Pract; 2021 Jul; 177():108873. PubMed ID: 34051282
[TBL] [Abstract][Full Text] [Related]
17. Correlation Between Carotid Intima Media Thickness and Non-Alcoholic Fatty Liver Disease.
Kumari S; Porwal YC; Gupta R
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443534
[TBL] [Abstract][Full Text] [Related]
18. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
Kim KS; Oh HJ; Kim DJ; Kim SK; Park SW; Cho YW; Huh KB
Endocr J; 2013; 60(12):1295-301. PubMed ID: 24047563
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease.
Serra-Planas E; Aguilera E; Castro L; Rodríguez R; Salinas I; Lucas A; Joaquín C; Puig R; Mauricio D; Puig-Domingo M
J Diabetes; 2017 Dec; 9(12):1065-1072. PubMed ID: 28220621
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W
J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
